Search Results 1911-1920 of 19409 for autoimmune hepatitis

1. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

   ... hepatitis B (patients with positive hepatitis B surface antigen [HBsAg] are excluded). For patients with positive hepatitis B core antibody [anti-HBc], ...

2. A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis - Mayo Clinic

   study and for 1 month after treatment discontinuation. Exclusion Criteria: Liver-related: 1. Documented causes of chronic liver disease other than NASH 2 ...

3. Comprehensive Imaging and Biomarker Assessment of Aortic Valve Stenosis - Mayo Clinic

   Any ongoing autoimmune disease; Any ongoing or recent (within 2 weeks) ... Severe liver disease; Any other valve disease ≥moderate; Women of child-bearing ...

4. A Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Participants with Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated with Janus Kinase (JAK) Inhibitor - Mayo Clinic

   Active systemic hepatitis infection requiring treatment (carriers of hepatitis ... liver disease including cirrhosis; Prior history of hematopoietic stem ...

5. Mayo Clinic News Network Title: Bioartificial Liver Research / Date: July 2015 Intro: On any given day about 15,000 Amer

   is dialysis for liver disease. The liver is more ... acetaminophen poisoning, medication reactions, Hepatitis and other viruses or autoimmune disease.

6. Sorafenib (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (eg, hepatitis) or; Stomach or bowel perforation (tear or hole) or; Thyroid problems—Use with caution. May make these conditions worse ...

7. Estradiol and levonorgestrel (transdermal route) - Mayo Clinic

   Liver disease or; Protein C or protein S deficiency, or other known blood clotting disorders or; Stroke, active or history of or; Surgery with a long period of ...

8. Mayo Clinic Q and A: Understanding hepatitis C

   Hepatitis C is a viral infection that causes inflammation and damage to the liver, requiring a liver transplant if not treated in time.

9. Golden Calf Trial - Mayo Clinic

   Significant liver disease (e.g. acute hepatitis, chronic active hepatitis, cirrhosis) or ALT (or AST) > 3 x ULN. (within last four weeks); Platelet count ...

10. Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome - Mayo Clinic

    Another highly active inflammatory/autoimmune ... Note: Subjects with stable autoimmune disease, (eg ... Hepatitis B virus (HBV) surface antigen (HBsAg) ...